Substance Use Treatment Facilities examined data from SAMHSA and other sources to see how teen drug use varies by state and ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...

Pharmacists and the state Department of Human Services say the change should never have been allowed because of the terms of ...

Alchemy, a developer of in-house pharmacy programs for clinics with large HIV and hepatitis C patient populations, raised $31 ...

As the nation's AIDS walk marks its 40th year in Los Angeles, organizers say medical advances have taken lowered visibility ...

One new study suggests that the drug dronabinol derived from cannabis could help reduce agitation in people with Alzheimer’s disease without significantly increasing the risk for adverse events.

(Reuters) - Johnson & Johnson (NYSE:JNJ) said on Friday it will discontinue a mid-stage field study of its experimental pill for prevention ... and pediatric HIV patients, respectively.

Gilead Sciences has announced that cheaper versions of its “gamechanger” HIV prevention drug, lenacapavir, will be made available in 120 low and middle income countries. Lenacapavir is an ...

Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, have non-exclusive, royalty-free licenses to produce generic ...